These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9028860)

  • 1. Dideoxyinosine-induced pancreatitis in human immunodeficiency virus-infected children.
    Levin TL; Berdon WE; Tang HB; Haller JO
    Pediatr Radiol; 1997 Feb; 27(2):189-91. PubMed ID: 9028860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine.
    Butler KM; Venzon D; Henry N; Husson RN; Mueller BU; Balis FM; Jacobsen F; Lewis LL; Pizzo PA
    Pediatrics; 1993 Apr; 91(4):747-51. PubMed ID: 7681940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatitis in children infected with human immunodeficiency virus.
    Koranyi KI; Brady MT; Stock K; Lucas P; Nahata MC
    Pediatr AIDS HIV Infect; 1996 Aug; 7(4):261-5. PubMed ID: 11361719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM; Bechtel LM; Starich GH
    Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic warning for ddI.
    AIDS Patient Care STDS; 2000 Feb; 14(2):101. PubMed ID: 10743523
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute pancreatitis with severe lactic acidosis in an HIV-infected patient on didanosine therapy.
    Allaouchiche B; Duflo F; Cotte L; Mathon L; Chassard D
    J Antimicrob Chemother; 1999 Jul; 44(1):137-8. PubMed ID: 10459826
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
    Martínez E; Milinkovic A; de Lazzari E; Ravasi G; Blanco JL; Larrousse M; Mallolas J; García F; Miró JM; Gatell JM
    Lancet; 2004 Jul 3-9; 364(9428):65-7. PubMed ID: 15234858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2',3'-Dideoxyinosine and pancreatic disease in HIV infection].
    Belda Mira A; Pascual Izuel JM; Gonzalvo Bellver F; Rovira Daudí E
    Med Clin (Barc); 1995 Mar; 104(8):319. PubMed ID: 7700097
    [No Abstract]   [Full Text] [Related]  

  • 9. Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI).
    Lai KK; Gang DL; Zawacki JK; Cooley TP
    Ann Intern Med; 1991 Aug; 115(4):283-4. PubMed ID: 1906693
    [No Abstract]   [Full Text] [Related]  

  • 10. Extended warning on Didanosine-related pancreatitis.
    Res Initiat Treat Action; 1999 Dec; 5(5):22-3. PubMed ID: 11366889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid lowering therapy in patients with HIV infection.
    McBride M; Chin MT; Lee SM; Kelly B
    Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug Points: pancreatitis associated with hydroxyurea in combination with didanosine.
    Longhurst HJ; Pinching AJ
    BMJ; 2001 Jan; 322(7278):81. PubMed ID: 11154621
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal pancreatitis as a complication of therapy for HIV infection.
    Pelucio MT; Rothenhaus T; Smith M; Ward DJ
    J Emerg Med; 1995; 13(5):633-7. PubMed ID: 8530781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pancreatitis as a common complication of 2',3'-dideoxyinosine therapy in the acquired immunodeficiency syndrome.
    Maxson CJ; Greenfield SM; Turner JL
    Am J Gastroenterol; 1992 Jun; 87(6):708-13. PubMed ID: 1590305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral-induced hepatic steatosis and lactic acidosis: case report and review of the literature.
    Ellozy S; Massen R; Chao L; Divino CM
    Am Surg; 2001 Jul; 67(7):680-3. PubMed ID: 11450788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute onset of pancreatitis with concomitant use of tenofovir and didanosine.
    Kirian MA; Higginson RT; Fulco PP
    Ann Pharmacother; 2004 Oct; 38(10):1660-3. PubMed ID: 15340130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of pancreatitis in HIV-infected patients: comment on findings in EuroSIDA cohort.
    Fessel J; Hurley LB
    AIDS; 2008 Jan; 22(1):145-7. PubMed ID: 18090403
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy.
    Butt AA
    AIDS Read; 2003 Jul; 13(7):344-8. PubMed ID: 12889452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ddI, d4T, Hydroxyurea: new pancreatitis warning.
    AIDS Treat News; 1999 Nov; (No 331):1-3. PubMed ID: 11367125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.
    García-Benayas T; Rendón AL; Rodríguez-Novóa S; Barrios A; Maida I; Blanco F; Barreiro P; Rivas P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2006 Apr; 22(4):333-7. PubMed ID: 16623636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.